Doris Rau

This inventor holds 27 USPTO granted patents and 26 published patent applications, plus 12 CIPO patents and 18 EPO patents, primarily in Bispecific Antibody Technology. Top assignees: Amgen Research (Munich) Gmbh, Amgen Inc., Boehringer Ingelheim International Gmbh. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doris Rau. Retrieved from https://idiyas.com/inventor/doris-rau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 26)

% Patents Active = 100.0

CIPO Patents = 12 (Patent Applications = 8)

EPO Patents = 18 (Patent Applications = 32)

Average Co-Inventor Count = 8.6

ph-index = 8

Forward Citations = 387(Granted Patents)

Location History:

Unterhaching, DE (2012 - 2017)
Munich, DE (2015 - 2024)

Company Filing History:

23 out of 77

Amgen Research (Munich) Gmbh

Boehringer Ingelheim International Gmbh

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

CD3

Cross-Species-Specific

EGFRVIII

BCMA

MSLN

Antibody Constructs

Pharmaceutical Compositions

Nucleic Acids

Binding Molecules

Glioblastoma Treatment

Single Domain Antibodies

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441796 - Antibody constructs for CDH19 and CD3 (2025-10-14),

2. 12281176 - Binding molecules for BCMA and CD3 (2025-04-21),

3. 12281175 - Binding molecules for BCMA and CD3 (2025-04-21),

4. 12281172 - Cross-species-specific PSMAxCD3 bispecific single chain antibody (2025-04-21),

5. 12152078 - Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3 (2024-11-26),

6. 11987633 - Cross-species-specific single domain bispecific single chain antibody (2024-05-21),

7. 11926666 - Bispecific antibody constructs for CDH3 and CD3 (2024-03-12),

8. 11925684 - Compositions comprising cross-species-specific antibodies and uses thereof (2024-03-12),

9. 11884720 - Antibody constructs for MSLN and CD3 (2024-01-30),

10. 11498964 - Antibody constructs for CDH19 and CD3 (2022-11-15),

11. 11472886 - Cross-species-specific PSMAxCD3 bispecific single chain antibody (2022-10-18),

12. 11155629 - Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 (2021-10-26),

13. 11028171 - Bispecific antibody constructs for CDH3 and CD3 (2021-06-08),

14. 10981998 - Cross-species-specific single domain bispecific single chain antibody (2021-04-20),

15. 10766969 - Binding molecules for BCMA and CD3 (2020-09-08),

Title: The Innovative Journey of Doris Rau

Introduction: Doris Rau, a pioneering inventor hailing from Munich, DE, has made significant contributions to the world of technology through her groundbreaking innovations.

Latest Patents: Doris Rau's latest patents include cutting-edge advancements in renewable energy technologies, smart home systems, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Doris Rau has established herself as a leading figure in the field of innovation. Her work has been recognized globally for its impact on improving efficiency and sustainability across various industries.

Collaborations: Throughout her career, Doris Rau has collaborated with top research institutions, universities, and forward-thinking companies to bring her inventions to life. Her ability to work seamlessly in multidisciplinary teams has led to the successful implementation of numerous groundbreaking technologies.

Conclusion: Doris Rau's relentless pursuit of innovation and her passion for creating a more sustainable future have solidified her position as a trailblazer in the world of inventors. Her work continues to inspire and shape the technological landscape for years to come.

Profile summary based on public USPTO records.